Colgate-Palmolive has risen more than 16% this year while also increasing its dividend.

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak ...

Colgate-Palmolive (NYSE:CL) is progressing with its 2030 plan, focusing on premium product offerings and a closer link ...

Is CL a good stock to buy? We came across a bullish thesis on Colgate-Palmolive Company on Compounding Dividends’s Substack.

NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive (NYSE:CL) President, Hill’s Pet Nutrition, John Hazlin, and Chief Investor Relations Officer and EVP, M&A, John Faucher, will participate in a fireside ...

Detailed price information for Colgate-Palmolive Company (CL-N) from The Globe and Mail including charting and trades.

Colgate-Palmolive (NYSE:CL) is set to give its latest quarterly earnings report on Friday, 2025-04-25. Here's what investors need to know before the announcement. Analysts estimate that ...

Ratings for Colgate-Palmolive (NYSE:CL) were provided by 7 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table summarizes their recent ratings, ...

Colgate-Palmolive (CL) is back in focus after recent share price moves and fresh performance data, giving investors a chance ...

Colgate-Palmolive Colgate-Palmolive (NYSE: CL) reported its Q1 results on April 26, with revenues and earnings above the street estimates. The company reported $5.1 billion revenue and $0.86 adjusted ...

Colgate-Palmolive is a Dividend King with a 62-year record of dividend growth and global dominance in oral care products. CL recently rebounded from a multi-year earnings decline, driven by its 2022 ...

Colgate-Palmolive Company announced today it has signed an agreement with the National Aeronautics and Space Administration (NASA) to explore innovative solutions to advance oral health, personal care ...